Seoul
South Korea
17
2021-12-16
11
2023-07-18
These are the the leading inventors for applications assigned to AVIXGEN INC.:
AVIXGEN INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CYTOPLASMIC TRANSDUCTION PEPTIDE AND INTRACELLULAR MESSENGER COMPRISING SAME
#2 | 2021-09-23 ✅ Patent 11,702,449 granted on 2023-07-18Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient
#3 | 2021-08-19PHARMACEUTICAL COMPOSITION COMPRISING FUSION PROTEIN OF CELL-PENETRATING PEPTIDE AND RPE65 FOR TREATMENT OF LEBER'S CONGENITAL AMAUROSIS
#4 | 2021-08-19 ✅ Patent 11,547,649 granted on 2023-01-10Fusion protein bound to cell-permeable peptide, and composition comprising fusion protein or cell-permeable peptide and epithelial cell growth factor as active ingredients
#5 | 2021-07-29PHARMACEUTICAL COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING OSTEOARTHRITIS, CONTAINING RHODANINE DERIVATIVE AS ACTIVE INGREDIENT
#6 | 2021-04-15PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE COMPLEX IMMUNODEFICIENCY COMPRISING FUSION PROTEIN OF CELL PENETRATING PEPTIDE AND ADENOSINE DEAMINASE
#7 | 2021-01-07 ✅ Patent 11,141,407 granted on 2021-10-12Pharmaceutical composition for preventing or treating aids comprising rhodanine derivative
#8 | 2020-06-18 ✅ Patent 11,208,433 granted on 2021-12-28Peptide for inhibiting skin inflammation and composition for preventing or treating skin inflammation containing the same
#9 | 2019-12-26 ✅ Patent 10,821,101 granted on 2020-11-03Pharmaceutical composition for preventing or treating AIDS comprising rhodanine derivative
#10 | 2019-10-17CYTOPLASMIC TRANSDUCTION PEPTIDE AND INTRACELLULAR MESSENGER COMPRISING SAME
#11 | 2019-10-17 ✅ Patent 11,040,999 granted on 2021-06-22Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient
#12 | 2018-07-12 ✅ Patent 10,231,971 granted on 2019-03-19Pharmaceutical composition for preventing and treating dry eye diseases, containing imatinib as active ingredient
#13 | 2017-02-09 ✅ Patent 9,969,771 granted on 2018-05-15Tetrapeptide having effect of inhibiting VEGF-induced angiogenesis and use thereof
#14 | 2013-04-18NOVEL THIOUREA OR UREA DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS, CONTAINING SAME AS ACTIVE INGREDIENT
#15 | 2013-04-18 ✅ Patent 8,759,536 granted on 2014-06-24Rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients
#16 | 2010-03-25 ✅ Patent 10,149,888 granted on 2018-12-11Method of inhibiting HIV replication utilizing the P7 nucleocapsid protein
#17 | 2010-02-25 ✅ Patent 9,738,905 granted on 2017-08-22Vector for expressing NC protein of HIV and method for producing NC protein using the same
Also check out AVIXGEN INC.'s (Seoul, South Korea) applicant profile with 8 patent applications submitted.
18618 ⎘